GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00068906 | Breast | IDC | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 10/1434 | 52/18723 | 5.49e-03 | 4.03e-02 | 10 |
GO:000689012 | Breast | DCIS | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 10/1390 | 52/18723 | 4.41e-03 | 3.41e-02 | 10 |
GO:000838010 | Cervix | CC | RNA splicing | 76/2311 | 434/18723 | 9.79e-04 | 8.19e-03 | 76 |
GO:00063684 | Cervix | CC | transcription elongation from RNA polymerase II promoter | 17/2311 | 69/18723 | 3.65e-03 | 2.33e-02 | 17 |
GO:00063545 | Cervix | CC | DNA-templated transcription, elongation | 20/2311 | 91/18723 | 6.88e-03 | 3.74e-02 | 20 |
GO:0008380 | Colorectum | AD | RNA splicing | 169/3918 | 434/18723 | 3.59e-18 | 2.04e-15 | 169 |
GO:0048193 | Colorectum | AD | Golgi vesicle transport | 109/3918 | 296/18723 | 1.80e-10 | 1.68e-08 | 109 |
GO:0006890 | Colorectum | AD | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 27/3918 | 52/18723 | 7.67e-07 | 2.70e-05 | 27 |
GO:0006888 | Colorectum | AD | endoplasmic reticulum to Golgi vesicle-mediated transport | 44/3918 | 130/18723 | 4.13e-04 | 4.68e-03 | 44 |
GO:0032786 | Colorectum | AD | positive regulation of DNA-templated transcription, elongation | 13/3918 | 27/18723 | 1.47e-03 | 1.25e-02 | 13 |
GO:0006354 | Colorectum | AD | DNA-templated transcription, elongation | 31/3918 | 91/18723 | 2.46e-03 | 1.90e-02 | 31 |
GO:0006368 | Colorectum | AD | transcription elongation from RNA polymerase II promoter | 24/3918 | 69/18723 | 5.35e-03 | 3.52e-02 | 24 |
GO:0008202 | Colorectum | AD | steroid metabolic process | 85/3918 | 319/18723 | 8.07e-03 | 4.75e-02 | 85 |
GO:00083801 | Colorectum | SER | RNA splicing | 123/2897 | 434/18723 | 3.84e-12 | 8.41e-10 | 123 |
GO:00481931 | Colorectum | SER | Golgi vesicle transport | 79/2897 | 296/18723 | 4.20e-07 | 2.15e-05 | 79 |
GO:00068901 | Colorectum | SER | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 20/2897 | 52/18723 | 4.80e-05 | 1.18e-03 | 20 |
GO:00068881 | Colorectum | SER | endoplasmic reticulum to Golgi vesicle-mediated transport | 34/2897 | 130/18723 | 1.13e-03 | 1.29e-02 | 34 |
GO:00083802 | Colorectum | MSS | RNA splicing | 159/3467 | 434/18723 | 1.75e-19 | 1.22e-16 | 159 |
GO:00481932 | Colorectum | MSS | Golgi vesicle transport | 101/3467 | 296/18723 | 9.09e-11 | 9.77e-09 | 101 |
GO:00068902 | Colorectum | MSS | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 26/3467 | 52/18723 | 2.66e-07 | 1.10e-05 | 26 |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ERG | MYOEPI | Breast | ADJ | AL590617.2,ITGA2,DST, etc. | 6.58e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Breast/Str/TF_ADJ/regulons_activity_in_dotplot.png) |
ERG | MYOEPI | Breast | Healthy | ITGB1,LIMA1,NRP2, etc. | 4.72e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Breast/Str/TF_Healthy/regulons_activity_in_dotplot.png) |
ERG | MYOEPI | Breast | Precancer | AL590617.2,ITGA2,DST, etc. | 6.16e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Breast/Str/TF_Precancer/regulons_activity_in_dotplot.png) |
ERG | STM | Cervix | Healthy | CYSLTR1,TPST2,DOP1B, etc. | 3.44e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Cervix/Str/TF_Healthy/regulons_activity_in_dotplot.png) |
ERG | SPI | Oral cavity | NEOLP | PROX1,ST6GALNAC3,STOX2, etc. | 1.83e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/OralCavity/Str/TF_NEOLP/regulons_activity_in_dotplot.png) |
ERG | MAST | Pancreas | ADJ | KCNG2,EPB41L1,KIT, etc. | 1.87e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Pancreas/Str/TF_ADJ/regulons_activity_in_dotplot.png) |
ERG | MAST | Pancreas | Healthy | KCNG2,EPB41L1,KIT, etc. | 2.65e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Pancreas/Str/TF_Healthy/regulons_activity_in_dotplot.png) |
ERG | MAST | Pancreas | PanIN | KCNG2,EPB41L1,KIT, etc. | 4.60e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Pancreas/Str/TF_PanIN/regulons_activity_in_dotplot.png) |
ERG | MAST | Pancreas | PDAC | KCNG2,EPB41L1,KIT, etc. | 3.19e-01 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Pancreas/Str/TF_PDAC/regulons_activity_in_dotplot.png) |
ERG | NKT | Pancreas | PDAC | KCNG2,EPB41L1,KIT, etc. | 9.03e-02 | ![The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.](images/gene_regulatory/Pancreas/Str/TF_PDAC/regulons_activity_in_dotplot.png) |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ERG | SNV | Missense_Mutation | | c.465N>T | p.Lys155Asn | p.K155N | P11308 | protein_coding | deleterious(0.04) | probably_damaging(0.966) | TCGA-A1-A0SO-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | | SD |
ERG | SNV | Missense_Mutation | novel | c.976N>A | p.Glu326Lys | p.E326K | P11308 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A2-A04Q-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
ERG | SNV | Missense_Mutation | | c.1267C>A | p.Pro423Thr | p.P423T | P11308 | protein_coding | tolerated(0.32) | benign(0.003) | TCGA-A2-A1FX-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD |
ERG | SNV | Missense_Mutation | novel | c.29N>T | p.Ala10Val | p.A10V | P11308 | protein_coding | tolerated_low_confidence(0.4) | benign(0) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ERG | SNV | Missense_Mutation | | c.120N>A | p.Met40Ile | p.M40I | P11308 | protein_coding | deleterious(0.05) | benign(0.358) | TCGA-E2-A159-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD |
ERG | SNV | Missense_Mutation | | c.401T>A | p.Val134Glu | p.V134E | P11308 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-GM-A2DF-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxol | CR |
ERG | insertion | Frame_Shift_Ins | novel | c.1309_1310insCA | p.Phe437SerfsTer12 | p.F437Sfs*12 | P11308 | protein_coding | | | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ERG | insertion | Nonsense_Mutation | novel | c.1307_1308insACAATCTGGAGATGTTACAAGTTTATGACTCATGA | p.Asn436LysfsTer10 | p.N436Kfs*10 | P11308 | protein_coding | | | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ERG | SNV | Missense_Mutation | | c.1123N>A | p.Ala375Thr | p.A375T | P11308 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ERG | SNV | Missense_Mutation | | c.749G>T | p.Arg250Ile | p.R250I | P11308 | protein_coding | deleterious(0.02) | possibly_damaging(0.866) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | MMV009085 | CHEMBL581225 | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | blocker | CHEMBL473 | DOFETILIDE | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | HOMIDIUM BROMIDE | HOMIDIUM BROMIDE | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | blocker | CHEMBL1700 | SOTALOL HYDROCHLORIDE | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | blocker | CHEMBL3545169 | AZD1305 | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | GNF-PF-1947 | CHEMBL585591 | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | blocker | CHEMBL2107762 | NERISPIRDINE | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | ACRIDIN-1-YLAMINE | CHEMBL146525 | |
2078 | ERG | DRUGGABLE GENOME, CLINICALLY ACTIONABLE | | IDARUBICIN HYDROCHLORIDE | IDARUBICIN HYDROCHLORIDE | |